Valeant Pharmaceuticals North America LLC recalls Librax (5 mg chlordiazepoxide HCl and 2.5 mg clidinium bromide) capsules, 100-count bottle, Rx Only, Manufactured in Ca…
- Recall date
- April 18, 2015
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-1034-2016
- FDA classification
- Class III
- Brand / firm
- Valeant Pharmaceuticals North America LLC
- Sold / distributed
- Nationwide and Puerto Rico
Why it was recalled
Failed Impurities/Degradation Specifications
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Librax (5 mg chlordiazepoxide HCl and 2.5 mg clidinium bromide) capsules, 100-count bottle, Rx Only, Manufactured in Canada by: Valeant Pharmaceuticals International, Inc., Steinbach, MB R5G 1Z7 Canada; Manufactured for: Valeant Pharmaceuticals North America LLC, Bridgewater, NJ 08807, NDC 0187-4100-10.
Get recall alerts
Free email alert whenever Valeant Pharmaceuticals North America LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Valeant Pharmaceuticals North America LLC